Your browser doesn't support javascript.
loading
Phase II study of S-1 in combination with trastuzumab for HER2-positive metastatic breast cancer.
Takashima, Tsutomu; Nakayama, Takahiro; Yoshidome, Katsuhide; Kawajiri, Hidemi; Kamigaki, Shunji; Tsurutani, Junji; Arai, Takashi; Ito, Toshikazu; Komoike, Yoshihumi; Doi, Takako; Masuda, Norikazu; Miyauchi, Keisuke; Miyoshi, Yasuo; Sakamoto, Junichi; Morita, Satoshi; Taguchi, Tetsuya.
Afiliação
  • Takashima T; Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan tsutomu-@rd5.so-net.ne.jp.
  • Nakayama T; Department of Breast and Endocrine Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan.
  • Yoshidome K; Department of Surgery, Osaka Police Hospital, Osaka, Japan.
  • Kawajiri H; Department of Surgical Oncology, Osaka City University Graduate School of Medicine, Osaka, Japan.
  • Kamigaki S; Department of Surgery, Sakai Municipal Hospital, Sakai, Japan.
  • Tsurutani J; Department of Medical Oncology, Kinki University Faculty of Medicine, Osaka, Japan.
  • Arai T; Takebe Breast Care Unit, Kagawa Japan.
  • Ito T; Department of Surgery, Rinku General Medical Center, Osaka, Japan.
  • Komoike Y; Department of Breast and Endocrine Surgery, Kinki University Faculty of Medicine, Osaka, Japan.
  • Doi T; Department of Breast Cancer Oncology, Shonan Memorial Hospital, Kanagawa, Japan.
  • Masuda N; Department of Surgery, Breast Oncology, NHO Osaka National Hospital,Osaka, Japan.
  • Miyauchi K; Miyauchi Clinic, Hyogo, Japan.
  • Miyoshi Y; Department of Breast and Endocrine Surgery, Hyogo College of Medicine, Hyogo, Japan.
  • Sakamoto J; Young Leaders' Program in Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Morita S; Department of Biostatistics and Epidemiology, Yokohama City University Medical Center, Kanagawa, Japan.
  • Taguchi T; Department of Endocrine and Breast Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Anticancer Res ; 34(7): 3583-8, 2014 Jul.
Article em En | MEDLINE | ID: mdl-24982373
Assuntos
Palavras-chave
Buscar no Google
Imprimir
XML
PubMed Links

Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article
Buscar no Google
Imprimir
XML
PubMed Links

Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Receptor ErbB-2 Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2014 Tipo de documento: Article